Click Here
1 known investors
FAST-PASE® is a blood-based allergy diagnostic test that measures mast cell activation in response to allergens, offering safer and more accurate results than traditional skin-prick or food challenge tests. The company focuses on developing diagnostics for common food allergens and other allergic conditions.
BiotechDigital HealthMedical Devices